Johnson & Johnson
JNJUpdated . Prices are snapshots and may be delayed.
Johnson & Johnson price chart
AI Outlook for Johnson & Johnson
Neutral postureJohnson & Johnson sits near neutral, with a modest long-term upside of +4.1% offset by a medium-term decline of -4.0%; short-term momentum is down -7.5% and the RSI sits at 43, while the 50-day average remains above the 200-day.
- Long-term trend+3.9% vs 200-day average
- Medium-term trend-4.3% vs 50-day average
- Averages50-day above 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Updated 15h ago. Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Johnson & Johnson performance
About Johnson & Johnson
Johnson & Johnson is a pharmaceuticals company based in the United States, listed on NEW YORK STOCK EXCHANGE, INC. since 1944 (ticker JNJ).
The shares trade at a price-to-earnings ratio of 29.1. The dividend yield is 3.12%.
Johnson & Johnson market data
What is the price of Johnson & Johnson today?
Johnson & Johnson (JNJ) is at $255.56, +0.02% on the day.
What is the 52-week range of Johnson & Johnson?
Over the past year Johnson & Johnson has traded between $184.66 and $281.07. It is currently 74% of the way up that range.
What is the P/E ratio of Johnson & Johnson?
Johnson & Johnson trades at a price-to-earnings ratio of 29.1.
Similar stocks
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.